China-U.S. IPO Pipeline Creaks Back to Life With Two New Listing Plans

Drug maker LianBio and hotel operator Atour each aims to raise about $350 million with separate New York listings Key takeaways: Two Chinese companies, drug maker LianBio and hotel operator Autour, are moving ahead with U.S. IPOs after a three-month pause on such listings Neither company is using the controversial VIE structure, and neither comes from the sensitive internet sector By Doug Young A year ago, the imminent IPO by Chinese company LianBio (LIAN.US) wouldn’t have drawn much attention. The biotech specialist’s offering is noteworthy for its large size, aiming…

Read More